Pancreatic cancer escape variants that evade immunogene therapy through loss of sensitivity to IFNgamma-induced apoptosis. (Q38522757)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12808437%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

title

Pancreatic cancer escape variants that evade immunogene therapy through loss of sensitivity to IFNgamma-induced apoptosis (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12808437%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

1 reference

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12808437%20AND%20SRC:MED&resulttype=core&format=json

Luis Alfonso Martínez-Cruz

4 November 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12808437%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12808437%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

Mazzolini G

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12808437%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

Narvaiza I

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12808437%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

Arina A

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12808437%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

Galofré JC

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12808437%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

Qian C

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12808437%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

Mato JM

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12808437%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

Melero I

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12808437%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

publication date

1 July 2003

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12808437%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12808437%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

volume

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12808437%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

issue

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12808437%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

page(s)

1067-1078

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12808437%20AND%20SRC:MED&resulttype=core&format=json

IL-12 gene therapy for cancer: in synergy with other immunotherapies

4 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301957

Intratumoral coinjection of two adenoviruses, one encoding the chemokine IFN-gamma-inducible protein-10 and another encoding IL-12, results in marked antitumoral synergy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301957

Combined CXC chemokine and interleukin-12 gene transfer enhances antitumor immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301957

Interleukin 12 and B7-1 costimulatory molecule expressed by an adenovirus vector act synergistically to facilitate tumor regression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301957

Large nontransplanted hepatocellular carcinoma in woodchucks: treatment with adenovirus-mediated delivery of interleukin 12/B7.1 genes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301957

Immunomodulatory gene therapy with interleukin 12 and 4-1BB ligand: long- term remission of liver metastases in a mouse model

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301957

Interleukin-12 and B7.1 co-stimulation cooperate in the induction of effective antitumor immunity and therapy of established tumors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301957

Intratumoral coinjection of adenoviral vectors expressing IL-2 and IL-12 results in enhanced frequency of regression of injected and untreated distal tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301957

Regression of colon cancer and induction of antitumor immunity by intratumoral injection of adenovirus expressing interleukin-12.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301957

Gene therapy of orthotopic hepatocellular carcinoma in rats using adenovirus coding for interleukin 12.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301957

Adenoviral vectors expressing lymphotactin and interleukin 2 or lymphotactin and interleukin 12 synergize to facilitate tumor regression in murine breast cancer models

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301957

Chemokines — Chemotactic Cytokines That Mediate Inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301957

CCR6, a CC chemokine receptor that interacts with macrophage inflammatory protein 3alpha and is highly expressed in human dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301957

Macrophage inflammatory protein 3alpha transgene attracts dendritic cells to established murine tumors and suppresses tumor growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301957

Unlocking the secrets of CTL and NK cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301957

Antigen-processing machinery breakdown and tumor growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301957

Implications for immunosurveillance of altered HLA class I phenotypes in human tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301957

Influence of interferon gamma on modulation of Fas expression by human colon carcinoma cells and their subsequent sensitivity to antigen-specific CD8+ cytotoxic T lymphocyte attack

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301957

Positive and negative consequences of soluble Fas ligand produced by an antigen-specific CD4(+) T cell response in human carcinoma immune interactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301957

Demonstration of an interferon gamma-dependent tumor surveillance system in immunocompetent mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301957

IFNgamma and lymphocytes prevent primary tumour development and shape tumour immunogenicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301957

Adenovirus-mediated interleukin-12 gene therapy for metastatic colon carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301957

Positive regulatory role of IL-12 in macrophages and modulation by IFN-gamma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301957

Murine macrophages secrete interferon gamma upon combined stimulation with interleukin (IL)-12 and IL-18: A novel pathway of autocrine macrophage activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301957

Cytokine-induced differentiation of precursor mouse CD8+ T cells into cytotoxic CD8+ T cells secreting Th1 or Th2 cytokines.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301957

Cellular responses to interferon-gamma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301957

Direct growth suppressive activity of interferon-alpha and -gamma on human gastric cancer cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301957

Interferon-gamma induced cell death in a cultured human salivary gland cell line

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301957

Interferon gamma (IFNgamma ) and tumor necrosis factor alpha synergism in ME-180 cervical cancer cell apoptosis and necrosis. IFNgamma inhibits cytoprotective NF-kappa B through STAT1/IRF-1 pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301957

Interferon-gamma-induced differentiation and apoptosis of HT29 cells: dissociation of (glucosyl)ceramide signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301957

Loss of STAT1 expression confers resistance to IFN-gamma-induced apoptosis in ME180 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301957

Tumor necrosis factor-alpha and interferon-gamma induce expression of functional Fas ligand on HT29 and MCF7 adenocarcinoma cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301957

Analysing gene expression data from DNA microarrays to identify candidate genes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301957

Saccharomyces Genome Database (SGD) provides secondary gene annotation using the Gene Ontology (GO)

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301957

Clusterin contributes to caspase-3-independent brain injury following neonatal hypoxia-ischemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301957

Apolipoprotein J/clusterin limits the severity of murine autoimmune myocarditis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301957

Claudin-4: a new target for pancreatic cancer treatment using Clostridium perfringens enterotoxin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301957

PAF produced by human breast cancer cells promotes migration and proliferation of tumor cells and neo-angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301957

Direct Intratumoral Injection of an Adenovirus Expressing Interleukin-12 Induces Regression and Long-Lasting Immunity That Is Associated with Highly Localized Expression of Interleukin-12

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301957

Small changes in expression affect predisposition to tumorigenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301957

Combined chemokine and cytokine gene transfer enhances antitumor immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301957

7 January 2021

The best cytokine for the job

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301957

7 January 2021

Gene ontology: tool for the unification of biology

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301957

7 January 2021

Interleukin-12: a cytokine at the interface of inflammation and immunity

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301957

7 January 2021

IRF-1-mediated CAS expression enhances interferon-gamma-induced apoptosis of HT-29 colon adenocarcinoma cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301957

7 January 2021

Spontaneous oxidative stress and liver tumors in mice lacking methionine adenosyltransferase 1A.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301957

7 January 2021

Ferritin and ceruloplasmin in oxidative damage: review and recent findings.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301957

7 January 2021